Comparison of the effectiveness of Cinnarizine V/S Topiramate in migraine prophylaxis of childre
Phase 3
Recruiting
- Conditions
- Migraine.Migraine
- Registration Number
- IRCT20221108056444N1
- Lead Sponsor
- Oroumia University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Children with migraine
The need for prophylactic treatment
Age 6-15 years
Exclusion Criteria
Patients with advanced migraine who need drugs other than painkillers
Previous history of receiving prophylactic treatment
Abnormal brain and nerve imaging and special conditions such as seizures, epilepsy or the presence of contraindications for the use of cinnarizine and topiramate
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Headache. Timepoint: At the beginning of the study, 1, 3, 6, 9, and 12 weeks after the start of treatment. Method of measurement: Migraine Questionnaire.
- Secondary Outcome Measures
Name Time Method